Ropinirole Hydrochloride (Ropinirole Hydrochloride) (Tablet) 0.25 mg/1

Ropinirole Hydrochloride is a prescription medication used to treat symptoms of Parkinson’s disease and restless legs syndrome. This 0.25 mg tablet form helps manage motor control and movement-related issues. Consult a healthcare provider for suitability. Short-term use only.

Strength

0.25 mg/1

Manufacturer / TM Owner

Aidarex Pharmaceuticals LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ropinirole Hydrochloride is primarily used to relieve symptoms associated with Parkinson’s disease, including tremors, muscle stiffness, and poor muscle control. It is also prescribed for restless legs syndrome to reduce the urge to move the legs, especially at night. This medication helps improve daily functioning by addressing movement-related discomfort.

Side Effects

Many users report improved mobility and reduced restlessness after taking Ropinirole Hydrochloride. Some may notice a gradual easing of muscle stiffness and better coordination over time. Common effects include mild drowsiness or dizziness, especially when starting treatment. Effects vary by individual and may take time to become noticeable.

Precautions & Warnings

Store Ropinirole Hydrochloride tablets at room temperature, away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about any ongoing medications or health conditions before use. Avoid sudden changes in dosage without professional guidance.

Avoid Interactions

Ropinirole Hydrochloride may interact with alcohol, sedatives, or other medications affecting the central nervous system. Caution is advised when combining with CYP1A2 inhibitors, as they can alter drug levels. Always disclose all medications to your doctor to prevent potential interactions. Monitor for increased side effects when using multiple CNS-active drugs.

Frequently Asked Questions

Ropinirole hydrochloride is used to treat symptoms of Parkinson’s disease and restless legs syndrome.

Effects may be noticed within a few weeks, but individual responses vary.

It can be taken with or without food, but consistency in timing is recommended.

Some users may experience drowsiness; avoid driving if affected until you know how it affects you.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.